ELISA was used to analyze the levels of CD147 and A33 on the fEVs of preoperative (n = 48) and postoperative (n = 29) CRC patients, aiming at assessing the possibility of employing these markers as prognostic reporters. This evidence concerns the gene GPA33 and colorectal carcinoma.